← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2011Last known activity
Nov 30, 2026
Timeline
1950s
- Jun 1, 1950
EMS S/A— Founded
Drugs by trial phase (110 distinct, 83 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (96 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Back Pain
- Cataract
- Common Cold
- Coronavirus Infections
- Cough
- Dermatitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Dyspepsia
- Dysuria
- Eczema
- Eosinophilic Esophagitis
- Erectile Dysfunction
- Esophagitis
- Glaucoma
- Glaucoma, Open-Angle
- Headache
- Herpes Genitalis
- Herpes Labialis
- Herpes Zoster
- Hyperplasia
- Hypersensitivity
- Hypertension
- Hypertriglyceridemia
- Infections
- Inflammation
- Memory Disorders
- Musculoskeletal Pain
- Obesity
- Ocular Hypertension
- Pneumonia
- Pneumonia, Viral
- Prostatic Hyperplasia
- Psoriasis
- Respiration Disorders
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Severe Acute Respiratory Syndrome
- Sleep Initiation and Maintenance Disorders
- Varicose Veins
Recent trials (50)
- NCT07030101Lead sponsorPhase 3Nov 30, 2026
- NCT05125978Lead sponsorPhase 2Sep 30, 2026
- NCT06268054Lead sponsorPhase 3Feb 28, 2025
- NCT06264414Lead sponsorPhase 3Feb 28, 2025
- NCT06237231Lead sponsorPhase 3Feb 15, 2025
- NCT06272409Lead sponsorPhase 3Feb 15, 2025
- NCT06555549Lead sponsorN/ASep 30, 2024
- NCT05886088Lead sponsorPhase 3Feb 29, 2024
- NCT05772338Lead sponsorN/AOct 31, 2023
- NCT05684380Lead sponsorPhase 3Sep 30, 2023
- NCT05824065Lead sponsorPhase 3Sep 30, 2023
- NCT05640232Lead sponsorPhase 3Sep 30, 2023
- NCT05800392Lead sponsorPhase 4Jul 3, 2023
- NCT05456152Lead sponsorPhase 3Jun 30, 2023
- NCT05144360Lead sponsorPhase 3Feb 28, 2023
Details
- Founded
- Hortolândia, BR Jun 1, 1950
- Last known activity
- Nov 30, 2026
Notes
--- Pre-folding founded info: 1964-01-01 Hortolandia None Brazil https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=5863889 ---